CHMP issues positive recommendation for approval of lecanemab in the EU

STOCKHOLM, Nov. 14, 2024 /PRNewswire/ — BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announces that EMA’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation regarding BioArctic’s partner Eisai’s marketing authorization application (MAA) for…